Leading Computer Assisted Radiology & Surgery Solutions
EDDA Technology, Inc. attend the 92th Scientific Assembly & Annual Meeting of the Radiological Society of North America.
MEETING DATES : Nov. 26 – Dec. 1, 2006
BOOTH NUMBER : South Building – Hall A3271
For more information: http://rsna2006.rsna.org/rsna2006/V2006/exhibitor_list/displayEx.cvn?exbID=1089
Princeton Junction, NJ, September 4, 2006
In this year’s “Minnies” nominations from Aunt Minnie, IQQA®-Liver has entered the list of semi-finalists for the category of “Best New Radiology Software”.
The “Minnies” are Aunt Minnie’s equivalent of the Academy Awards in radiology.
For more information about this news, please visit:
http://www.auntminnie.com/index.asp?Sec=nws&sub=rad&pag=dis&ItemId=72245&wf=1215
April 27, 2006
Agreement with diagnostic image analysis software developer to enable earlier disease diagnosis
Austin, Texas – At the Society for Computer Applications in Radiology’s (SCAR) annual meeting, Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced that it has entered a strategic partnership with EDDA Technology to provide advanced digital radiography solutions to assist in the detection of lung lesions. Philips has licensed EDDA Technology’s IQQA®-Chest software, which is designed to help clinicians identify, quantify, evaluate and report pulmonary nodules. The innovative software will be available as part of the Philips digital radiography portfolio, providing an integrated hardware and software solution.
By bridging the gap between the clinician’s interpretation based upon patient-specific knowledge and computer analysis of the information captured by the X-ray, IQQA®-Chest helps clinicians increase their performance while improving the efficiency for the analysis of each image. The first real-time interactive diagnostic analysis system, IQQA®-Chest integrates advanced computer analysis technology into the clinicians’ diagnostic process.
“Through our partnership with EDDA Technology we’re providing clinicians with a new set of tools to aid in their detection of lung lesions at an early stage,” commented Dr. Peter Reimer, global marketing director General X-Ray, Philips Medical Systems. “IQQA®-Chest complements our extensive radiography product portfolio and will ultimately lead to greater diagnostic confidence, resulting in better quality of care for patients.”
“Our partnership with Philips reflects the increasingly important role that advanced computer assistance plays in the diagnosis of potentially life-threatening diseases,” said Dr. Jian-Zhong Qian, president and CEO of EDDA Technology. “By combining IQQA®-Chest with the broad Philips digital radiography portfolio clinicians can benefit from a powerful diagnostic solution across a wide range of equipment types. We are pleased about the strategic alliance with Philips and look forward to working closely together in future developments of our innovative solution.”
IQQA®-Chest will be available in combination with the entire Philips digital radiography portfolio, including DigitalDiagnost, the company’s state-of-the art solution for direct digital radiography. The product will initially be available in the United States and China where the product has received regulatory clearance, and will become available in additional countries from 2007.
A demonstration of IQQA®-Chest will be featured on the Philips booth at the SCAR annual meeting, booth number 623.
IQQA® is a registered trademark of EDDA Technology, Inc.
For further information please contact:
Philips:
US
Steve Kelly
Tel: +1 425 487 7479
steve.kelly@philips.comEurope
Gert van Santen
Tel: +31 40 27 82682
gert.van.santen@philips.comEDDA Technology
Xiaolan Zeng
xzeng@edda-tech.com
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is one of the world’s biggest electronics companies and Europe’s largest, with sales of $37.7 billion(EUR 30.4 billion) in 2005. With activities in the three interlocking domains of healthcare, lifestyle and technology and 161,498 employees in more than 60 countries, it has market leadership positions in medical diagnostic imaging and patient monitoring, color television sets, electric shavers, lighting and silicon system solutions.
News from Philips is located at www.philips.com/newscenter.
About EDDA Technology
EDDA Technology, Inc. is a clinical computer solution provider in diagnostic imaging and analysis. EDDA offers a series of new generation software products to enable early detection of diseases and to enhance precision in diagnosis and treatment.EDDA’s goal is to deliver advanced information analysis technologies that improve clinical workflow and accuracy.A privately held Delaware corporation, EDDA is headquartered in Princeton Junction, New Jersey, and has a subsidiary in Shanghai, China.
More information about EDDA is located at www.edda-tech.com
For more information about this partership, please visit
http://www.medical.philips.com/main/news/content/file_1101.html
http://www.medical.philips.com/main/products/xray/products/radiography/cad_chest/
Shanghai, PR China, November 28, 2005 – The Chinese State Food Drug Administration (SFDA) has approved the IQQA®-Liver software.
This Princeton, NJ, advanced visualization software developer will demonstrate new enhancements to its software for analyzing chest and liver images.
The company debuted version 1.0 of its IQQA-Chest software for viewing digital radiography chest images at the 2004 RSNA meeting. The software is designed to help physicians identify, quantify, diagnose, and report pulmonary nodules.
At this year’s show, EDDA will highlight version 1.1 of the software, with advanced DICOM connectivity (including DICOM Storage, Query/Retrieval, Structured Report, Send, and other protocols) and a refined work list design that further improves workflow efficiency, according to the company.
EDDA will also report on a clinical study, conducted in five hospitals in China, in which the software was used for CT-confirmed nodules. The study suggests that the software improved detection of lung nodules in screening populations, using both DR and CR technology, according to the company. The results have been accepted for presentation at this month’s RSNA meeting.
EDDA will introduce IQQA-Liver, new work-in-progress software to enhance workflow in dynamic liver imaging. The application is intended to assist the review of serial multiphase CT acquisitions of the liver using dynamic imaging techniques. It offers advanced visualization and quantitative evaluation tools powered by image registration and segmentation techniques, the vendor said. It can be used to diagnose and stage primary liver disease and liver metastases, and for preoperative assessment.
IQQA-Liver is undergoing clinical studies in China and is pending regulatory review by U.S. and Chinese regulatory agencies.
By Brian Casey
AuntMinnie.com staff writer
November 17, 2005
EDDA Technology (Booth #1505) is highlighting its flagship IQQA®-Chest v1.0 that debuted at RSNA 2004, as well as showing as a works in progress IQQA®-Liver system – both from the Intelligent/Interactive Qualitative and Quantitative Analysis (IQQA®) series of products.
IQQA®-Chest is a software system designed for soft-copy reading of digital radiographic chest images that assists physicians in the identification, quantitative evaluation, diagnosis and reporting of pulmonary nodules. EDDA points out that the latest clinical study involving five hospitals in China on CT-confirmed nodules suggested improved performance in detecting lung nodules from screening populations using both DR and CR technology. (The results have been accepted for oral presentation at RSNA 2005.)
EDDA recently released IQQA®-Chest v1.1 featuring advanced DICOM connectivity (including DICOM storage, Query/Retrieval, Structured Report and Send) and a refined worklist design to further enhance workflow efficiency.
IQQA®-Liver, which is pending FDA approval (which could come prior to showtime), is geared toward enhancing workflow for the application of dynamic liver imaging that is challenged by data overflow from multislice CT. Namely with 32- and 64-detector CT, the number of slices in a dynamic CT series can easily reach a few thousand, with at least four phases acquired in a typical dynamic CT study with contrast. IQQA®-Liver is designed to assist the review of serial multi-phase CT acquisitions of the liver using dynamic imaging techniques. It offers advanced visualization and quantitative evaluation tools empowered by image registration and segmentation techniques and can be used in the diagnosis and staging of primary liver disease and liver metastases as well as in pre-operative assessment. Clinical testing of the system has been conducted in two hospitals in China.
EDDA Technology, Inc.
Attend the 91th Scientific Assembly & Annual Meeting of the Radiological Society of North America.
MEETING DATES : Nov. 27 – Dec. 1, 2005
BOOTH NUMBER : South Building – Hall A1505
Shanghai, PR China, June 26, 2005
EDDA Technology, Inc attended the first International Congress of Comprehensive Interventional Therapy on Hepatocellular Carcinoma in Shanghai (Jun 25-26), organized by the Society of Radiology of China, the Shanghai Institute of Medical Imaging, and Zhongshan Hospital of Fudan University.
In the conference, Dr. Xiaolan Zeng, VP of EDDA Tech, gave a presentation titled “Evaluation and Diagnosis of Liver Lesions with Computer Assistance using Dynamic MDCT”, and demonstrated the recent R&D results in computer-aided detection, diagnosis, and treatment of small liver cancers. The report generated great interest, excitement, and positive feedbacks among the conference participants. During the panel session following the presentation, Dr. Jianzhong Qian and Dr. Zeng, further joined the in-depth discussion about this emerging computer technology.Consensus was reached by participating researchers and clinicians on the usefulness of such computer technologies in the application for liver cancer detection, diagnosis and treatment.
EDDA Technology was a new vendor on the RSNA floor debuting its IQQA®-Chest v1.0 soft-copy chest CAD product that seeks to help in physician’s identification and quantification of small lung nodules and lesions in digital radiographic chest images. EDDA calls it Intelligent/Interactive Qualitative and Quantitative Analysis.
IQQA®-Chest supports physicians in the visualization, identification, evaluation and reporting of pulmonary lesions and nodules. Geared toward optimizing workflow, the system features a three-task approach, with an Image Reading page, Region of Interest (ROI) Analysis page and Clinical Report page. The Image Reading page features a DICOM-compliant patient study selection, image visualization toolkits with multiple nodule-specific viewing modes and mechanisms for physicians to mark and select lesions. ROI Analysis page features include the display of patient and imaging related information from DICOM, lesion/nodule segmentation in automatic and manual mode, instantaneous automatic computation of quantitative measurements from segmentation results (length, width, average size, area, circularity, mean intensity, density) and means for physicians to input the diagnosis (likelihood of malignancy). And the Clinical Report page provides automatic generation of a clinical report that includes measurements upon physician-confirmed diagnosis, the physician with a way to input notes and digital signature and secures the report with a time stamp and a report ready for printing or storage in DICOM Structured Report format.
The IQQA®-Chest software “helps reduce inter-observer variation and to improve the detection rate of small nodules” according to a study presented in October at the 11th International Conference on Screening for Lung Cancer in Rome.
IQQA®-Chest is available for sale in the U.S. as well as the E.U. and China. EDDA is embarking on a sales strategy of direct and OEM generated sales. Two units have been installed in China.
Princeton Junction, NJ, November 22, 2004
Imaging software company EDDA Technology announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its debut product, IQQA®-Chest software, an image analysis system that is specifically tailored for the softcopy review of digital chest radiographic images.
The IQQA®-Chest software carries the CE mark, and was also cleared by the Chinese State Food and Drug Administration for marketing and production in October 2004.
IQQA®-Chest is the first real-time interactive diagnostic analysis system, offering comprehensive tools not only for the identification but also for the quantification of nodules detected with projection chest radiography, the most commonly performed imaging procedure. In identifying nodules, physicians are able to use lesion-specific image enhancement viewing (LSEV) modes that dynamically detail image structures and highlight suspicious areas suggesting nodular abnormalities. Once suspect nodules are identified, the software offers regional analysis tools for the quantification of lesion characteristics including size, density and shape.
Combining lesion-specific image enhancement viewing and ROI (region of interest) evaluation tools, the software is designed to help radiologists with the identification, confirmation and quantification of pulmonary lesions. The software offers DICOM connectivity and automatically assembles diagnostic information into a clinical report for referring physicians and follow-up review. The “plug-and-play” software runs on standard PC platform.
“EDDA’s vision is to seamlessly integrate advanced diagnostic analysis technology into physicians’ softcopy reading process for improved workflow and clinical decision making,” said Jian-Zhong Qian, PhD, president and CEO of EDDA Technology. “Bridging the detection of pulmonary nodules with accurate characterization, IQQA®-Chest bolsters the image quality and workflow efficiency advantages of thoracic digital X-Ray. This combination will have a broad impact on improving nodule case diagnosis and patient prognosis, especially as digital X-Ray continues to gain market acceptance and acceleration.”
A clinical study presented last month at the 11th International Conference on Screening for Lung Cancer in Rome, Italy, suggested that the IQQA®-Chest software could help to reduce inter-observer variation and to improve the detection rate of small nodules. Conducted by Dr. Wei Song and Dr. Zhenyu Jin at the Peking Union Medical College Hospital in Beijing, China, the study involved the review of 232 chest DR cases from screening patients by physicians of different experience levels.